Hepatitis B

Hepatitis B (HBV) is a blood-borne virus that attacks the liver causing both acute and chronic disease. Two billion people worldwide are infected with the virus, 240 million live with chronic HBV infection and 780,000 people die each year due to HBV related illness.

It is 50 times more infectious than HIV but unlike HIV, there is a vaccine available which is 95 percent effective. Vaccinating a baby in the first 24 hours of life against the virus is potentially lifesaving, yet millions of children in resource-poor countries are still missing out.

HBV can be transmitted through sexual intercourse, sharing drug injecting equipment or from mother to baby.

Donate today!

Use my gift where the need is greatest

Current Projects

  • Healthy Mothers, Healthy Babies

  • Hepatitis B discrimination and health service access.

  • Identifying the barriers to hepatitis B clinical management: the perspectives of people with hepatitis B.

  • Identifying the structural enablers to the clinical management of people with hepatitis B in general practice: a qualitative investigation

  • Improving Hepatitis B Virus screening in general practice in Victoria

  • Methods for improved sensitivity of lateral flow tests

  • SHARP: Screening for Hepatitis in At-Risk Populations

  • SuperMIX: The Melbourne Injecting Drug User Cohort Study

  • The B-VAX Project: Hep B vaccinations for people who inject drugs

Past Projects

  • ALT point-of-care diagnostic to detect liver disease